scispace - formally typeset
L

Lin Wang

Researcher at Zhengzhou University

Publications -  74
Citations -  2439

Lin Wang is an academic researcher from Zhengzhou University. The author has contributed to research in topics: Glioma & Carcinogenesis. The author has an hindex of 26, co-authored 66 publications receiving 1871 citations. Previous affiliations of Lin Wang include Thomas Jefferson University & Nanjing Medical University.

Papers
More filters
Journal ArticleDOI

Genome-wide association study identifies a new susceptibility locus for cleft lip with or without a cleft palate

TL;DR: A case-control-based GWAS followed by two rounds of replication is conducted to elucidate the genetic architecture of NSCL/P in China and provides additional evidence that the rs2235371-related haplotype at 1q32.2 could play a more important role than the previously identified causal variant rs642961 in Chinese populations.
Journal ArticleDOI

MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers.

TL;DR: Levels in human blood and tumor tissues are associated with CRC cancer occurrence, metastasis and drug resistance, and miR-143 levels may be used as a new diagnostic marker and therapeutic target for CRC in the future.
Journal ArticleDOI

Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy

TL;DR: MIR152 is reported as a new autophagy-regulating miRNA that plays a role in cisplatin-resistance and it is found that EGR1 (early growth response 1) regulated the MIR152 gene at the transcriptional level.
Journal ArticleDOI

MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma

TL;DR: It is demonstrated that miR-143 plays a significant role in inactivating the RAS signaling pathway through the inhibition of N-RAS, which may provide a novel therapeutic strategy for treatment of glioma and other RAS-driven cancers.
Journal ArticleDOI

MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras

TL;DR: MiR-124 levels in tumor tissues are associated with glioma occurrence, angiogenesis, and chemoresistance and that miR- 124 may be used as a new diagnostic marker and therapeutic target forglioma in the future.